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In this podcast we talk to Prof David Kupfer about the challenges, controversies and future directions of DSM-5 by
considering other research frameworks and classification systems of disease, and how this revised psychiatric
diagnostic manual will impact global mental health classification and the field of medicine.
The podcast for this interview is available at: http://www.biomedcentral.com/sites/2999/download/Kupfer.mp3Introduction
Prof David Kupfer chairs the American Psychiatric Asso-
ciation Task Force for the fifth Edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM-5)
and is the Thomas Detre Professor of Psychiatry and
Professor of Neuroscience and Clinical and Transla-
tional Science at the University of Pittsburgh School of
Medicine. Prof Kupfer’s research has focused primarily
on long-term treatment strategies for recurrent mood
disorders, the pathogenesis of depression and the rela-
tionship between biomarkers and depression. He is the
Founding President of the International Society of Bipo-
lar Disorders, has authored or co-authored a combin-
ation of more than 1,021 articles, books and book
chapters and has been the recipient of numerous awards
and honors (Figure 1).
DSM-5 was released at the American Psychiatric
Association’s Annual Meeting in May 2013 and it
marked the end of more than a decade’s journey in
revising the criteria for the diagnosis and classification of
mental disorders.
The podcast for this interview is available at: http://www.
biomedcentral.com/sites/2999/download/Kupfer.mp3.Edited transcript
1. Why was the revision to DSM-5 required?
The revision to DSM-5 was required as it has been
nearly 20 years since the Diagnostic and Statistical
Manual of Mental Disorders was last updated and we
have learned a lot about mental disorders since then.Correspondence: kupferdj@upmc.edu
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mental disorders more precisely. DSM-5 does that by
representing the best available science and clinical
experience. This new manual is a guidebook that will
help clinicians better serve their patients.2. What, in your opinion, are the main challenges for
DSM-5?
As with other DSMs, the fifth edition reflects the state
of our current scientific knowledge. When we started
the process of developing this manual 14 years ago, I
think we were all very optimistic that there would be
biomarkers and other breakthroughs of a magnitude that
would allow us to use biological measures as part of our
disorder criteria sets. This has not happened yet, but
DSM-5 does provide the best clinical guidebook possible
to diagnose mental disorders.3. What are the controversies around DSM-5 in light of
other diagnostic frameworks such as the Research
Domain Criteria (RDoC)?
DSM and the RDoC programme, which is being
developed by the National Institute of Mental Health
(NIMH), represent complementary but not competing
frameworks. As the RDoC effort takes shape over the
next 5 to 10 years, any information or findings
stemming from its research agenda will be incorpo-
rated into future DSM editions to further strengthen
patient care, just as all advances up until now have
done. The American Psychiatric Association (APA)
and NIMH worked together very closely during thehis is an Open Access article distributed under the terms of the Creative
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that partnership we can continue to move the field of
mental health forward in meaningful ways.
4. Will DSM-5 affect global mental health classification?
We knew that the manual would go far beyond the bor-
ders of the United States. Thus we sought to involve as
many parts of the world as early as we could. We were
able to do this by conducting 13 international conferences
between 2003 and 2008. Half of the scientists and clini-
cians involved in these conferences were from outside
North America and represented 39 countries. The confer-
ences were jointly supported by the APA, 3 institutes of
the National Institutes of Health [NIH] and the World
Health Organisation [WHO]. We also worked closely with
WHO to develop harmonization between the diagnostic
criteria included in both DSM-5 and the forthcoming 11th
Revision of the International Classification of Diseases bet-
ter known as ICD-11. The DSM and the ICD are compan-
ion publications aligned in the technical aspects of
diagnostic codes as well as in their organization of disor-
ders. These changes will facilitate improved communica-
tion and common use of diagnoses around the globe.
5. What are the future directions for DSM-5, for example
how will it affect medicine in general?
This is a very important question. First, the American
Psychiatric Association is working to make DSM-5 avail-
able in multiple formats. In addition to the hardcover,
paperback and online versions, they are working on anapp design for smart phones and devices and a few other
ways to help broaden the methods by which people
everywhere can use DSM-5.
In developing the manual itself, we also made the
criteria and text more user-friendly for physicians and
clinicians outside of psychiatry. This is particularly
important because most patients visit their primary
care physician and not a psychiatrist when experien-
cing psychiatric symptoms. DSM-5′s use of definable
thresholds across a continuum of normality mirrors
that of general medicine’s assessment practice. The
well-defined thresholds in DSM-5 will aid physicians in
more accurately determining those who need professional
help and those who do not.
It’s also important to remember that DSM-5 does not
represent an end or the final word. We won’t be
waiting another 20 years to update it. Our job in devel-
oping the DSM-5 was to synthesize all the advances
achieved over the past 20 years and reflect that in the
manual while allowing room for growth. This was the
most interesting challenge of DSM-5 and also we be-
lieve its greatest success. I am personally pleased with
the finished product, extremely proud of the contribu-
tion that it represents to the future of mental health,
and the major contribution of many individuals around
the world. We are very eager to see how we can im-
prove it in the coming years.
6. Where can I find out more?
See references [1-9].
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